Paper I
2025 August (Supplementary) (2010 Scheme) · 40 marks · 120 min

Question

Selective COX-2 inhibitors.

Q190.3 marksShort Answers

Answer

Celecoxib, Etoricoxib — selectively inhibit COX-2 while sparing COX-1, reducing prostaglandin-mediated inflammation/pain with substantially lower GI ulceration risk than non-selective NSAIDs, though at increased cardiovascular (thrombotic) risk with prolonged use.

Other Years Asked


Revise MBBS
Preview